Skip to main content
Livermore
Livermore
ZHEN

Wealthspire Advisors, LLC

SEC CIK
0001646247
Latest filing
Aug 11, 2026

GALT holding history

Galectin Therapeutics Inc in every 13F filed by Wealthspire Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GALT overviewAll 13F holders of GALTFull Q2 2026 holdings

Shares (Q2 2026)
721,788
Value
$3.35M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of GALT by Wealthspire Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026721,788$3.35M<0.1%00.0%UnchangedHolders
Q1 2026721,788$2.01M<0.1%+119,815+19.9%AddedHolders
Q4 2025601,973$2.50M<0.1%+122,455+25.5%AddedHolders
Q3 2025479,518$2.03M<0.1%00.0%UnchangedHolders
Q2 2025479,518$1.01M<0.1%+81,144+20.4%AddedHolders
Q1 2025398,374$486.0K<0.1%00.0%UnchangedHolders
Q4 2024398,374$513.9K<0.1%00.0%UnchangedHolders
Q3 2024398,374$1.10M<0.1%00.0%UnchangedHolders
Q2 2024398,374$900.3K<0.1%00.0%UnchangedHolders
Q1 2024398,374$952.1K<0.1%+214,512+116.7%AddedHolders
Q4 2023183,862$305.2K<0.1%00.0%UnchangedHolders
Q3 2023183,862$353.0K<0.1%00.0%UnchangedHolders
Q2 2023183,862$264.8K<0.1%00.0%UnchangedHolders
Q1 2023183,862$386.1K<0.1%+183,862NewHolders
Q4 20220$00.0%−17,355−100.0%Sold outHolders
Q3 202217,355$28.0K<0.1%00.0%UnchangedHolders
Q2 202217,355$23.0K<0.1%00.0%UnchangedHolders
Q1 202217,355$28.0K<0.1%+3,500+25.3%AddedHolders
Q4 202113,855$29.0K<0.1%00.0%UnchangedHolders
Q3 202113,855$54.0K<0.1%00.0%UnchangedHolders
Q2 202113,855$44.0K<0.1%00.0%UnchangedHolders
Q1 202113,855$30.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.